Cytochrome P450 expression and activities in rat, rabbit and bovine tongue

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 136, Issue 4, 2003, Pages 297-308

  Yang, Shin Pei ^a   Medling, Theresa ^a   Raner, Gregory M ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Activity; Bovine; Cytochrome P450; Microsomes; Rabbit; Rat; RT PCR; Tongue

Indexed keywords

1 PHENYLETHANOL; 4 NITROPHENOL; 7 ETHOXYCOUMARIN; CAFFEINE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2E1; CYTOCHROME P450 3A6; CYTOCHROME P450 4A4; CYTOCHROME P450 INHIBITOR; ISOENZYME; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CATALYSIS; CATTLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE; EXPERIMENTAL RAT; HYDROXYLATION; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING; SPECIES COMPARISON; SPECIES DIFFERENCE; STATISTICAL SIGNIFICANCE; TONGUE;

BOVINAE; ORYCTOLAGUS CUNICULUS;

EID: 0842346111     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2003.10.003     Document Type: Article

References (44)

1. Ahmad N., Agarwal R., Mukhtar H. Cytochrome P-450 and drug development for skin diseases. Skin Pharmacol. 9:1996;231-241.
2. Aitken A.E., Roman L.J., Loughran P.A., de la Garza M., Masters B.S. Expressed CYP4A4 metabolism of prostaglandin E(1) and arachidonic acid. Arch. Biochem. Biophys. 393:2001;329-338.
3. Amato G., Longo V., Mazzaccaro A., Gervasi P.G. Chlorzoxazone 6-hydroxylase and p-nitrophenol hydroxylase as the most suitable activities for assaying cytochrome P450 2E1 in cynomolgus monkey liver. Drug Metab. Dispos. 26:1998;483-489.
4. Andreasson L., Bjorlin G., Laurell P., Trell E., Korsgaard R. Oral and oropharyngeal cancer, aryl hydrocarbon hydroxylase inducibility and smoking. A follow-up study. ORL J. Otorhinolaryngol. Relat. Spec. 47:1985;131-138.
5. Bestervelt L.L., Vaz A.D., Coon M.J. Inactivation of ethanol-inducible cytochrome P450 and other microsomal P450 isozymes by trans-4-hydroxy-2-nonenal, a major product of membrane lipid peroxidation. Proc. Natl. Acad. Sci. USA. 92:1995;3764-3768.
6. Butler M.A., Iwasaki M., Guengerich F.P., Kadlubar F.F. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA. 86:1989;7696-7700.
7. Ding X.X., Coon M.J. Purification and characterization of two unique forms of cytochrome P-450 from rabbit nasal microsomes. Biochemistry. 27:1988;8330-8337.
8. Duell E.A., Astrom A., Griffiths C.E., Chambon P., Voorhees J.J. Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro. J. Clin. Invest. 90:1992;1269-1274.
9. Farin F.M., Bigler L.G., Oda D., McDougall J.K., Omiecinski C.J. Expression of cytochrome P450 and microsomal exposide hydrolase in cervical and oral epithelial cells immortalized by human papillomavirus type 16 E6/E7 genes. Carcinogenesis. 16:1995;1670.
10. Gijare P.S., Rao K.V., Bhide S.V. Inhibitory effects of snuff extract on ornithine decarboxylase and aryl hydrocarbon hydroxylase activities in relation to cell proliferation of mouse tongue epithelial cells. Indian J. Exp. Biol. 28:1990;1012-1016.
11. Gu L., Gonzalez F.J., Kalow W., Tang B.K. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics. 2:1992;73-77.
12. Guengerich F.P., Mason P.S. Immunological comparison of hepatic and extrahepatic cytochromes P-450. Mol. Pharmacol. 15:1979;154-164.
13. Guengerich F.P. Analysis and characterization of enzymes. Hayes A.W. Principles and Methods of Toxicology. third ed:1994;1259-1311 Raven Press Ltd, New York.
14. Gushchin B.V., Gushchin M.I., Gerber N., Boyd R.T. A novel cytochrome P450 3A isoenzyme in rat intestinal microsomes. Biochem. Biophys. Res. Commun. 255:1999;394-398.
15. Hung H.C., Chuang J., Chien Y.C., et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidem. Biomar. Prev. 6:1997;901-905.
16. Jenner J., Dodd G.H. Xenobiotic metabolism in the nasal epithelia. Drug Metabol. Drug Interact. 6:1988;123-148.
17. Jiang Y., Kuo C.L., Pernecky S.J., Piper W.N. The detection of cytochrome P450 2E1 and its catalytic activity in rat testis. Biochem. Biophys. Res. Commun. 246:1998;578-583.
18. Katiyar S.K., Matsui M.S., Mukhtar H. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J. Invest. Dermatol. 114:2000;328-333.
19. Kharasch E.D., Thummel K.E., Mhyre J., Lillibridge J.H. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1. Clin. Pharmacol. Ther. 53:1993;643-650.
20. Lakshmi V.M., Zenser T.V., Davis B.B. Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N′-diacetylbenzidine. Drug Met. Dispos. 25:1997;481-488.
21. 2-terminal membrane-insertion signal peptide does not alter the catalytic activities. Proc. Natl. Acad. Sci. USA. 88:1991;9141-9145.
22. Lechevrel M., Casson A.G., Wolf C.R., et al. Characterization of cytochrome P450 expression in human oesophageal mucosa. Carcinogenesis. 20:1999;243-248.
23. McCabe T.J., Roman L.J., Masters B.S. Induction of rabbit lung CYP4A4 prostaglandin omega-hydroxylase by various steroid hormones. Arch. Biochem. Biophys. 393:2001;78-86.
24. Moncion A., Truong N.T., Garrone A., Beaune P., Barouki R., De Waziers I. Identification of a 16-nucleotide sequence that mediates post-transcriptional regulation of rat CYP2E1 by insulin. J. Biol. Chem. 277:2002;45904-45910.
25. Morita K., Maeda Y., Masuda M., et al. Strain differences in CYP3A-mediated C-8 hydroxylation (1,3,7-trimethyluric acid formation) of caffeine in Wistar and Dark Agouti rats. Rapid metabolism of caffeine in debrisoquine poor metabolizer model rats. Biochem. Pharmacol. 55:1998;1405-1411.
26. Nebert D.W. Drug-metabolizing enzymes in ligand-modulated transcription. Biochem. Pharmacol. 47:1994;25-37.
27. Nef P., Heldman J., Lazard D., et al. Olfactory-specific cytochrome P-450. cDNA cloning of a novel neuroepithelial enzyme possibly involved in chemoreception. J. Biol. Chem. 264:1989;6780-6785.
28. Nishimura M., Yaguti H., Yoshitsugu H., Naito S., Satoh T. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakuga. Zasshi. 123:2003;369-375.
29. Park J.Y., Muscat J.E., Ren Q., et al. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidem. Biomark. Prev. 6:1997;791-797.
30. Peng H.M., Coon M.J. Regulation of rabbit cytochrome P450 2E1 expression in HepG2 cells by insulin and thyroid hormone. Mol. Pharmacol. 54:1998;740-747.
31. Raner G.M., Hatchell A.J., Morton P.E., Ballou D.P., Coon M.J. Stopped-flow spectrophotometric analysis of intermediates in the peroxo-dependent inactivation of cytochrome P450 by aldehydes. J. Inorg. Biochem. 81:2000;153-160.
32. Raner G.M., Muir A.Q., Lowry C.W., Davis B.A. Farnesol as an inhibitor and substrate for rabbit liver microsomal P450 enzymes. Biochem. Biophys. Res. Commun. 293:2002;1-6.
33. Sai Y., Dai R., Yang T.J., et al. Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450. Xenobiotica. 30:2000;327-343.
34. Shimizu M., Lasker J.M., Tsutsumi M., Lieber C.S. Immunohistochemical localization of ethanol-inducible P450IIE1 in the rat alimentary tract. Gastroenterology. 99:1990;1044-1053.
35. Spatzenegger M., Hosmans Y., Verbeeck R.K. Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats. Pharmacol. Toxicol. 86:2000;71-77.
36. Tjalve H., Lofberg B. Extrahepatic sites of metabolism of carbon tetrachloride in rats. Chem. Biol. Interact. 46:1983;299-316.
37. Tsuneoka Y., Matsuo Y., Higuchi R., Ichikawa Y. Characterization of the cytochrome P450IID subfamily in bovine liver. Nucleotide sequences and microheterogeneity. Eur. J. Biochem. 208:1992;739-746.
38. Vaz A.D., Coon M.J. On the mechanism of action of cytochrome P450: evaluation of hydrogen abstraction in oxygen-dependent alcohol oxidation. Biochemistry. 33:1994;6442-6449.
39. Vondracek M., Xi Z., Larsson P., Baker V., Mace K., Pfeifer A., Tjalve H., Donato M.T., Gomez-Lechon M.J., Grafstrom R.C. Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogensis. 22:2001;481-488.
40. Walker N.J., Portier C.J., Laz S.F. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p- dioxin. Toxicol. Appl. Pharmacol. 154:1999;279-286.
41. Wohcikowski H., Pichard-Garcia L., Maurel, Pand Daniel W.A. Contribution of human cytochrome P-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine. Br. J. Pharmacol. 138:2003;1465-1474.
42. Worrall S.F., Corrigan M., High A., et al. Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6. Pharmacogenetics. 8:1998;433-439.
43. Yoo M., Ryu H.M., Shin S.W., et al. Identification of cytochrome P450 2E1 in rat brain. Biochem. Biophys. Res. Commun. 231:1997;254-256.
44. Zhukov A., Ingelman-Sundberg M. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase. Biochem. J. 340:1999;453-458.